Johnson & Johnson (JNJ) Work In Process (2012 - 2018)
Johnson & Johnson's (JNJ) quarterly Work In Process came in at $2.1 billion in Q4 2018, down 8.98% year-over-year from $2.3 billion in Q4 2017, and up 6.19% quarter-over-quarter from $2.0 billion in Q3 2018.
Analysis
Johnson & Johnson (JNJ) Work In Process (2012 - 2018) Analysis & Trends
Johnson & Johnson has disclosed Work In Process across 6 years of filings, most recently posting $2.1 billion for Q4 2018.
- In Q4 2018, Work In Process fell 8.98% year-over-year to $2.1 billion; the TTM figure through Dec 2018 stood at $2.1 billion (down 8.98% YoY), while the FY2018 annual figure was $2.1 billion, down 8.98% from the prior year.
- Work In Process came in at $2.1 billion for Q4 2018 at Johnson & Johnson, up from $2.0 billion in the prior quarter.
- In the past five years, Work In Process ranged from a high of $2.5 billion in Q4 2014 to a low of $2.0 billion in Q3 2018.
- Average Work In Process over 4 years is $2.2 billion, with a median of $2.2 billion recorded in 2016.
- Year-over-year, Work In Process gained 6.04% in 2017 and slipped 8.98% in 2018.
- Over 4 years, Work In Process stood at $2.5 billion in 2014, then decreased by 8.94% to $2.2 billion in 2016, then increased by 3.39% to $2.3 billion in 2017, then declined by 8.98% to $2.1 billion in 2018.
- Per Business Quant data, the three most recent Work In Process figures were $2.1 billion in Q4 2018, $2.0 billion in Q3 2018, and $2.3 billion in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.92 Bn | 621.16 Bn | 17.26 Bn |
| 2 | AbbVie | 448.34 Bn | 441.78 Bn | 12.70 Bn |
| 3 | Merck | 357.85 Bn | 350.70 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.35 Bn | 259.66 Bn | 11.24 Bn |
| 5 | Pfizer | 156.52 Bn | 144.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.91 Bn | 42.91 Bn | - |
| 8 | Incyte | 24.69 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.43 Bn | 18.77 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.79 Bn | 15.40 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 30, 2018 | 2.11 Bn |
| Sep 30, 2018 | 1.99 Bn |
| Jul 1, 2018 | 2.28 Bn |
| Dec 31, 2017 | 2.32 Bn |
| Jan 1, 2017 | 2.19 Bn |
| Jan 3, 2016 | 2.24 Bn |
| Dec 28, 2014 | 2.46 Bn |
| Dec 29, 2013 | 2.61 Bn |
| Dec 30, 2012 | 2.26 Bn |
| Jan 1, 2012 | 1.64 Bn |